DekaBank Deutsche Girozentrale’s Foundation Medicine, Inc. FMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-490
Closed -$67K 1261
2018
Q2
$67K Sell
490
-16,560
-97% -$1.5M ﹤0.01% 1126
2018
Q1
$1.36M Sell
17,050
-2,350
-12% -$173K 0.01% 644
2017
Q4
$738K Hold
19,400
0.01% 749
2017
Q3
$738K Hold
19,400
0.01% 758
2017
Q2
$787K Hold
19,400
0.01% 748
2017
Q1
$632K Sell
19,400
-1,600
-8% -$39.9K 0.01% 696
2016
Q4
$397K Buy
21,000
+1,600
+8% +$34.5K ﹤0.01% 697
2016
Q3
$439K Hold
19,400
﹤0.01% 691
2016
Q2
$358K Buy
19,400
+4,600
+31% +$83.1K ﹤0.01% 748
2016
Q1
$255K Sell
14,800
-2,700
-15% -$43.5K ﹤0.01% 797
2015
Q4
$379K Buy
17,500
+300
+2% +$5.78K ﹤0.01% 743
2015
Q3
$317K Buy
17,200
+900
+6% +$22.5K ﹤0.01% 781
2015
Q2
$552K Buy
16,300
+2,900
+22% +$117K 0.01% 685
2015
Q1
$645K Buy
+13,400
New +$608K 0.01% 659

DekaBank Deutsche Girozentrale's FMI Position: Q3 2018 in Review

DekaBank Deutsche Girozentrale sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 490 shares — an estimated $67K sold.

DekaBank Deutsche Girozentrale first reported a position in FMI in Q1 2015 and held it in 14 quarters. The position peaked at $1.36M in Q1 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

  • DekaBank Deutsche Girozentrale reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 490 Foundation Medicine, Inc. shares in Q3 2018, an estimated $67K.
  • DekaBank Deutsche Girozentrale first reported a position in Foundation Medicine, Inc. in Q1 2015 and held it in 14 quarters.
  • DekaBank Deutsche Girozentrale's Foundation Medicine, Inc. position peaked at $1.36M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2018, filed 9 Nov 2018.